← Open Payments lookup

JILL DEFIBAUGH: Open Payments

NPI 1225018914 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,312 in 47 payments from 25 companies in 2025. Trend: 2023 $1,657 · 2024 $814 · 2025 $1,312

Food & beverage: $1,219Education: $93
CompanyPaymentsAmount
Gilead Sciences, Inc.8$313
Amgen Inc.1$125
AstraZeneca Pharmaceuticals LP4$105
Takeda Pharmaceuticals U.S.A., Inc.3$82
Janssen Biotech, Inc.3$76
Novartis Pharmaceuticals Corporation3$69
Genentech USA, Inc.3$63
Merck Sharp & Dohme LLC3$60
Iovance Biotherapeutics, Inc.1$46
Eisai Inc.2$40

Products named: Trodelvy, IMDELLTRA (AMG757), RYBREVANT, NINLARO, Amtagvi, Lenvima, Venclexta, KEYTRUDA.

Industry payments across VA — which companies pay providers there.